Israeli firm
More News
-
Israel's CytoReason secures $80 million in funding to expand AI disease models
Nvidia, Pfizer, Thermo Fisher and OurCrowd invest to boost CytoReason's AI capabilities and data expansion
-
Israeli firm can steal phone data in seconds
The company shot to global prominence when the FBI used its technology
